1. Introduction {#sec1}
===============

Quinoline antimalarial drugs have long been implicated as a cause of hearing loss, tinnitus, dizziness, and severe imbalance ([@bib3]; [@bib15]; [@bib28]; [@bib31]). This side effect profile prompted the transition from quinine to chloroquine, and further development of hydroxychloroquine ([@bib28]; [@bib47]; [@bib48]). Chloroquine and hydroxychloroquine are structurally related to the natural product anti-malarial quinine ([@bib1]; [@bib53]). Chloroquine and hydroxychloroquine are synthesized from readily available starting materials and are more widely used than quinine which is obtained by extraction from the bark of the cinchona tree. The pharmacokinetic and toxicological properties of chloroquine and hydroxychloroquine are similar although subtle differences exist. While examples of toxic side effects including ototoxicity of chloroquine and hydroxychloroquine can be found in the literature ([@bib5]; [@bib10]), hydroxychloroquine is generally considered less toxic of the two ([@bib27]; [@bib29]). Chloroquine interferes with parasite growth in red blood cells, thereby protecting against or disrupting the progression of malaria ([@bib18]; [@bib20]). Despite the development of new drugs for the prevention and treatment of malaria, their ototoxic side effects have persisted.

Chloroquine and hydroxychloroquine have many uses in addition to being anti-malarial agents, and may therefore cause adverse events in multiple patient populations. Chloroquine or hydroxychloroquine are also commonly prescribed to treat autoimmune and collagen conditions such as rheumatoid arthritis, scleroderma, and systemic lupus erythematosus, as well as amebiasis ([@bib3]; [@bib28]) and other off-label applications ([@bib1]; [@bib4]; [@bib40]); these patients are more likely to experience ear-related symptoms due to the higher dosing and prolonged exposure to chloroquine. Most recently chloroquine has been promoted as a therapeutic against coronavirus disease COVID-19 ([@bib9]; [@bib46]; [@bib55]).

Patients receiving chloroquine may experience sensorineural hearing loss---as extreme as a complete loss of mid- and high-frequency hearing---([@bib31]), tinnitus ([@bib3]), and vestibular deficits such as vestibular paresis ([@bib28]; [@bib31]), as quickly as 2 h after an injection of chloroquine ([@bib32]). These side effects are all associated with the inner ear sensory structures, raising the suspicion of objective ototoxicity. Hydroxychloroquine has been associated with similar side effects, with over 700 reported adverse events linked to the ear and labyrinthine structure in the United States in the last 5 years ([@bib51]).

Unfortunately, knowledge of adverse effects has largely come from case studies, leaving the mechanisms and prevalence of these effects to be unclear. Both reversible ([@bib3]; [@bib31]) and irreversible ([@bib3]; [@bib28]; [@bib50]) symptoms concerning hearing and balance have been reported, but there is little understanding how these antimalarial drugs affect the structures of the inner ear and central nervous system involved in hearing and balance. Additionally, there is a lack of animal studies exploring the direct effects of chloroquine and hydroxychloroquine on the peripheral auditory system, and specifically, on mechanosensory hair cells. Here, we use the zebrafish lateral line and mouse neonatal cochlear cultures to test the effect of chloroquine and hydroxychloroquine on mechanosensory hair cell survival.

The zebrafish lateral line is a good model for understanding hair cell function and dysfunction ([@bib14]; [@bib35]; [@bib39]). The lateral line is a system of mechanosensory hair cells on the surface of the body that allows fish to detect fluid displacement. Inputs from this system provide a way for fish to orient themselves in water for behaviors such as schooling and predator avoidance ([@bib2]; [@bib49]). The system consists of neuromasts, clusters of hair cells surrounded by supporting cells. These hair cells depolarize as their stereocilia are displaced and send signals to the brain via associated nerve fibers, similar to the functions of hair cells in the auditory and vestibular labyrinth. Lateral line hair cells are easily accessible for experimental manipulation and provide a rapid system for screening compounds for ototoxicity ([@bib6]; [@bib17]; [@bib36]) as well as investigating the specific mechanisms of toxin entry into the cell and subsequent cell death ([@bib13]). In addition, the zebrafish lateral line system has been used to screen for small molecules that protect hair cells from damage, with translation to mammalian systems ([@bib7]; [@bib24]). Previous work in this system has largely focused on aminoglycoside antibiotics and cisplatin, known ototoxins that cause irreversible hearing and balance disorders in human patients. We then compared the effect of chloroquine in lateral line hair cells, an *in vivo* system, to their effect on neonatal mouse cochlear cultures, an established *in vitro* model for hair cell toxicity ([@bib25]; [@bib41]). Other known ototoxins cause comparable loss of hair cells in both systems ([@bib23]; [@bib24]).

Here, we report that chloroquine causes specific loss of mechanosensory hair cells in the zebrafish lateral line and in the cultured neonatal mouse cochlea. We find rapid, dose-dependent cell death due to exposure to these compounds. We suggest that chloroquine-associated hearing loss and vestibular impairment in human patients may be due to loss of hair cells and warrants further study *in vivo* in mature mammals.

2. Methods {#sec2}
==========

Procedures have been approved by the University of Washington Animal Care and Use Committee.

2.1. Zebrafish studies {#sec2.1}
----------------------

Adult zebrafish (*Danio rerio*) were paired to produce embryos in the University of Washington fish facility. Embryos raised at 50 embryos per 100 mm^2^ petri dish in E2 embryo medium (14.97 mM NaCl, 500 μM KCl, 42 μM Na2HPO4, 150 μM KH2PO4, 1 mM CaCl2 dihydrate, 1 mM MgSO4, 0.714 mM NaHCO3, pH 7.2) and raised in an incubator at 28.5 °C. At four days post-fertilization (dpf), larvae were fed live rotifers.

At 5--7 dpf, larvae were placed in 48-well plates with 10--12 larvae per well, each well containing a different concentration of chloroquine in 300 μL of embryo medium. This study used concentrations ranging from 25 to 1600 μM with either 1- or 24-h exposure periods. Concentrations were determined using common effective concentrations of aminoglycosides studied in this lab. Effects of hydroxychloroquine were investigated up to 400 μM.

Following exposure to the drug, zebrafish larvae were euthanized and then fixed in 4% paraformaldehyde overnight. Larvae were rinsed with phosphate-buffered saline (PBS) and then placed in blocking solution (1% Triton-X 100, 5% normal goat serum (NGS) in PBS) at room temperature for 1--2 h. Zebrafish were then placed in an anti-parvalbumin antibody solution (Sigma-Aldrich, MAB1572; monoclonal, 1:400 in 1% Triton-X, 1% NGS, in PBS) at 4 °C overnight and then rinsed with 1% Triton-X 100 in PBS (PBS-T) thrice. Larvae were then placed in a secondary solution with Alexa 488 goat anti-mouse H + L fluorescent antibody (ThermoFisher, A-11001; 1:500, in 1% Triton-X 100, 1% NGS, in PBS) for 4 h. Following the secondary antibody solution, zebrafish were rinsed with PBS-T and PBS, before being mounted with Fluoromount-G (Southern Biotech, Birmingham, AL, USA) between two coverslips (VWR Cat \#84393-251). Hair cells were counted in four neuromasts (SO1, SO2, O1, and OC1) per fish using a Zeiss Axioplan II microscope at a total magnification of 200X (40X objective; N.A. = 0.75) with FITC filtered fluorescent illumination.

2.2. Cochlear cultures {#sec2.2}
----------------------

Cochlear cultures were prepared from C57BL/6 J mice according to previously described protocols ([@bib24]; [@bib45]). Explants were prepared from pups sacrificed at postnatal day 2 and plated on collagen covered coverslips with 50 μL of cochlear culture medium (93% DMEM-F12, 7% FBS and 10 μg/ml ampicillin). The culture and coverslip were incubated overnight in a Maximow slide assembly at 37 °C.

Experiments were carried out in 2 ml total volume of modified culture media (98.6% DMEM-F12, 1.4% FBS and 10 μg/ml ampicillin) with varying concentration of chloroquine. After 24 h of incubation, cultures were washed once with PBS, fixed in 4% paraformaldehyde for 1 h at room temperature. Hair cells were labeled with 1:1000 Phalloidin conjugated to Alexa Fluor 568 (ThermoFisher, A12380) and 1:1000 anti-Myosin-VIIa rabbit polyclonal antibody (Santa Cruz, sc-74516), 1:1000 anti-Sox2 polyclonal antibody overnight followed by 1:500 Alexa Fluor 488 and 1:500 Alexa Fluor 694 goat anti-rabbit IgG (ThermoFisher, A-11034).

Tissue was imaged at the midpoint of the apical region and at the midpoint of the basal region of the cochlear coil using an Axioplan ll (Zeiss) upright microscope at a final magnification of 200x. MyosinVIIa labeled hair cell bodies and Sox2 labeled supporting cell nuclei were counted in a 100 μm length along the sensory epithelium of each microscope field. A statistical power analysis based on previous experiments in this system, with an alpha of 0.05 and power = 0.80 indicated that a minimum of n = 4 samples per group would be required ([@bib43]).

2.3. Data analysis {#sec2.3}
------------------

Total hair cells remaining were compared to counts of the same neuromasts of untreated fish or untreated cochlear cultures to calculate the percentage of hair cells remaining. Hair cell survival was then related to concentration of chloroquine used in incubation. Data was analyzed by t-tests, and by one-way or two-way ANOVAs with posthoc comparisons using GraphPad Prism.

3. Results {#sec3}
==========

To test the potential toxic effects of chloroquine, zebrafish were treated with differing concentrations of drug. Neuromasts displayed clearly visible hair cell death after treatment for 24 h ([Fig. 1](#fig1){ref-type="fig"} A and B), with increasing hair cell loss after exposure to increasing chloroquine concentrations during 24 h exposure ([Fig. 1](#fig1){ref-type="fig"}C). Significant differences in hair cell numbers were found between control conditions and concentrations of 100 μM and higher (100, 200, 400, 800, 1600) (p \< 0.05). Hair cell survival reached an apparent asymptote around 65% with concentrations of 400 μM and higher (400, 800, 1600). In subsequent experiments, concentrations were limited to 0--400 μM dosages. [Fig. 1](#fig1){ref-type="fig"}D compares the effects of treating zebrafish with chloroquine for 1 h and 24 h. Two-way ANOVA with dose and exposure time as main factors yielded a highly significant main effect of concentration (F = 30.99, p \< 0.0001), and a small effect of exposure time (F = 3.06, p = 0.0828), but the interaction term was highly significant (F = 4.5, p = 0.0009). These results demonstrate that chloroquine exposure results in a rapid dose-dependent loss of zebrafish lateral line hair cells that increase with increasing time of exposure.Fig. 1Chloroquine causes dose-dependent hair cell loss in the zebrafish lateral line system. Fluorescent imaging showed robust hair cell numbers in control neuromasts (A) and reduced numbers in fish exposed to 400 μM chloroquine for 24 h (B). Hair cell counts show a decrease in hair cell viability as chloroquine concentration increased (F = 12.28, p \< 0.0001; C). However, there was no significant change with concentrations from 400 μM to 1600 μM (p \> 0.05). (D) This pattern was consistent between 24- and 1- hour exposure times with no statistical significance (F = 3.06, p = 0.0828). Error bars represent ±1 standard deviation. Scale bar = 10 μm.Fig. 1

As hydroxychloroquine is often used to replace chloroquine in clinical settings, these two drugs were compared for relative hair cell toxicity. Both drugs showed dose-dependent hair cell loss ([Fig. 2](#fig2){ref-type="fig"} ). Hydroxychloroquine showed slightly more toxicity than chloroquine. Two-way ANOVA revealed significant main effects of drug concentration (F = 36.42; P \< 0.001) and drug product (F = 4.77, p = 0.03) with an insignificant interaction (F = 0.63, p = 0.644). These results demonstrate that both clinically-relevant chloroquine drugs show hair cell toxicity in the zebrafish model.Fig. 2Hydroxychloroquine causes dose-dependent effects on hair cells in the zebrafish lateral line, similar to chloroquine. Dose-response functions show that hair cells exposed to hydroxychloroquine (solid line) survive at a similar rate as those exposed to chloroquine (dashed line) after a 24-h treatment period. Two-way ANOVA demonstrate a small, but significant effect, with hydroxychloroquine being slightly more toxic (F = 4.774, p = 0.03). Error bars represent ±1 standard deviation.Fig. 2

Previous work has demonstrated that quinoline drugs, including chloroquine, can inhibit aminoglycoside ototoxicity by partially blocking mechanotransduction-dependent toxin uptake ([@bib35]). We reasoned that the asymptotic nature of the chloroquine dose-response function might be due to its ability to block its own uptake. We performed two sets of experiments to test this idea. Function of the mechanotransduction channel was assessed through quantification of FM1-43X uptake after pre-treatment with chloroquine at doses that cause maximal hair cell death. Fish were also treated with benzamil, a MET channel blocker known to block drug uptake ([@bib13]; [@bib44]) as a positive control ([Fig. 3](#fig3){ref-type="fig"} ). Chloroquine pre-treatment did not significantly alter FM1-43X uptake (p = 0.2334; Dunn's multiple comparison test), while benzamil-treated fish showed a highly significant decrease in FM1-43X uptake compared to controls (p \< 0.0001; [Fig. 3](#fig3){ref-type="fig"}A--D). We then examined whether chloroquine toxicity itself was altered by MET blockers ([Fig. 4](#fig4){ref-type="fig"} ). Neither 50 μM nor 200 μM benzamil co-treatment had a significant effect on chloroquine toxicity (p = 0.9698 and 0.4943, respectively; Sidak's multiple comparison test). Together these experiments suggest that the plateau of the dose-response function is not due to chloroquine effects on mechanotransduction.Fig. 3Chloroquine does not reduce MET channel activity. Fluorescent imaging showed no reduction of FM1-43-X uptake with pre-exposure to chloroquine (A--C). Brn3c fish, that have green fluorescent membrane markers, had no pre-treatment (A--A"), 1000 μM chloroquine for 15 min (B--B"), or 200 μM benzamil for 15 min (C--C"). Dunn's multiple comparisons confirmed that red fluorescence is not significantly attenuated in fish pre-treated with a high dose of chloroquine (p = 0.2334), while uptake is significantly lower in those fish treated with benzamil (p \< 0.0001), a known MET channel blocker (D; n = 6--8 fish per condition). Error bars represent ±1 standard deviation. Scale bar = 10 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 3Fig. 4Chloroquine-induced cell death is not affected by the presence of a MET channel blocker. Co-treatment of chloroquine and benzamil showed no significant change in hair cell viability, though chloroquine exposure did have a small but significant effect on hair cell survival (p \< 0.0001; n = 8--9). Error bars represent ±1 standard deviation.Fig. 4

To test whether mammalian hair cells degenerate in response to chloroquine, neonatal mouse cochlear cultures were exposed to 0--200 μM chloroquine for 24 h ([Fig. 5](#fig5){ref-type="fig"} ). Higher concentrations were not used in this model system due to extensive damage to cultures at 400 μM in pilot experiments and near total hair cell loss in basal regions at 200 μM. We compared responses of cultures from apical ([Fig. 5](#fig5){ref-type="fig"}B) and basal ([Fig. 5](#fig5){ref-type="fig"}C) regions of the cochlea. Apical regions showed no significant main effects of cell type (inner vs outer hair cell) or drug concentration and no significant interaction term interaction term. Analyses of the basal coil revealed that outer hair cells were significantly damaged (p \< 0.001) with 50% loss at 100 μM chloroquine exposure and almost complete loss was seen at 200 μM exposure, while there was a significant loss (p \< 0.05) of approximately 25% inner hair cells at the highest concentration. Statistical analysis (two-way ANOVA) revealed increasing hair cell loss with increasing chloroquine exposure (F = 23.68, p \< 0.0001), basal outer hair cells were significantly more sensitive to chloroquine than inner hair cells (F = 26.11, p \< 0.0001) and a significant interaction term (F = 7.65, p = 0.0009). In order to evaluate any effects of chloroquine on supporting cells, Sox2-positive cells located between the inner hair cells and first row of outer hair cells were counted and compared to controls. A two-way ANOVA indicated no significant reduction of supporting cell survival in either the apex or the base of cultures at any exposure to chloroquine concentration. Together these results demonstrate that chloroquine damage at the concentrations tested is targeted to the hair cells and, like most other ototoxic drugs, most severely compromises basal turn outer hair cells as compared to inner hair cells.Fig. 5Chloroquine exposure causes dose-dependent hair cell loss in neonatal mouse organ of Corti cultures. (A) Fluorescent imaging of basal turn cultures treated with 0, 50, 100, and 200 μM chloroquine and labeled with antibodies specific to hair cells (Myosin Vlla), or organ of Corti supporting cells (Sox2), or all nuclei (DAPI). Note that 50 μM chloroquine exposure (row labeled 50 μM CQ) did not reveal clear loss or disruption of any cell type (compare with top row (0 μM CQ). However, 100 μM and 200 μM chloroquine exposure resulted in moderate and extreme loss of outer hair cells, respectively. Conversely, there was no obvious loss of other cell types at any treatment condition. (B) Apical coil cultures demonstrate little or no loss of inner or outer hair cells following treatment with chloroquine at any of the concentrations used (p = 0.6087). (C) Basal coil hair cells, however, showed significantly decreased viability when treated with chloroquine (p \< 0.0001), and outer hair cells in the base were more dramatically affected by drug exposure than inner hair cells (F = 26.11, p \< 0.0001). Error bars represent ±1 standard deviation. Scale bar = 20 μm.Fig. 5

4. Discussion {#sec4}
=============

This study describes dose-response analyses for the effects of chloroquine in the zebrafish anterior lateral line and in neonatal murine cochlear cultures. Chloroquine exposure was found to cause hair cell loss in both models. In zebrafish, variation in exposure time (1 h vs 24 h) did not result in significant differences in hair cell loss, implying that chloroquine uptake is rapid and affects hair cells soon after they are exposed. Exposure to hydroxychloroquine yielded comparable results to those from chloroquine exposure. For mouse cochlear cultures, reduction in hair cell counts were most dramatic in basal regions and in outer hair cells, consistent with differences in the sensitivity of hair cells to other ototoxins and reported hearing loss being limited to or most profound at high frequencies with most other ototoxins ([@bib57]; [@bib7]; [@bib25]). While there are no *in vivo* mammalian studies to compare with the results presented here, these results are consistent with the absence of hair cells with fetal exposure to chloroquine seen in a temporal bone case study ([@bib28]).

Chloroquine and hydroxychloroquine have good oral bioavailability and reach high plasma levels in patients. Their pharmacokinetic profiles indicate extremely long elimination half-lives on (weeks to months) and large volumes of distribution indicating significant partitioning into tissues including cerebrospinal fluid ([@bib56]). Given these pharmacokinetic characteristics, it is entirely possible that drug concentration in the inner ear reach micromolar concentrations used in the experiments described here.

Because quinine users commonly reported similar side effects to that of patients taking chloroquine, it can be posited that the effects of these structurally-related quinoline drugs with the tissues of the inner ear are comparable. These results are consistent with reports of audiological and vestibular dysfunction after quinine treatment for malaria prophylaxis or treatment ([@bib16]; [@bib21]; [@bib33]; [@bib38]; [@bib42]). Studies of quinine ototoxicity have shown extensive damage and deterioration of the stria vascularis and organ of Corti, especially to outer hair cells ([@bib16]). Exposed animals displayed minimal damage in the vestibular system, and impacted vestibular function recovered with time. Peripheral auditory function was reduced with quinine injections---acutely exposed animals improved fully or partially, and those receiving chronic dosing remained affected.

The mechanism by which chloroquine acts to kill hair cells is not yet known. The pharmacological mechanisms of action of chloroquine are subject of some controversy but is widely considered to be due to its accumulation in lysosomes and subsequent disruption of their function ([@bib22]). Lysosomes have emerged as organelles with critical signaling roles regulating many aspects of cellular function (reviewed by [@bib54]). They also play central roles in autophagy, the process by which cellular components are recycled (reviewed in [@bib37]). Chloroquine's effects on lysosomes are likely to have effects on diverse downstream cellular processes including receptor signaling, with anti-inflammatory consequences ([@bib52]), and autophagy, with anti-tumor effects ([@bib26]). There may therefore be multiple effects of chloroquine on hair cell function with consequences to their survival.

While both zebrafish and mouse cochlear hair cells are sensitive to chloroquine, there are differences in the nature of the dose-response functions. Loss of zebrafish hair cells approached an asymptote of about 40% reduction without further loss at higher concentrations of chloroquine, while basal outer hair cells in mouse cochlear cultures approach 100% loss with increasing dose. The underlying causes of asymptotic nature of the zebrafish dose-response function is unknown. We hypothesized that chloroquine may reduce its uptake and toxicity at higher concentrations by blocking hair cell mechanotransduction, a property required for the hair cell entry of some other compounds in zebrafish, including aminoglycosides and cisplatin ([@bib49]; [@bib13]). Although other quinoline loop derivatives have been shown to interfere with mechanotransduction ([@bib11]; [@bib35]), we found little effect of chloroquine on mechanotransduction-dependent FM1-43 dye uptake in zebrafish. Moreover we found that interfering with mechanotransduction had little effect on chloroquine toxicity. We suggest that there may be other reasons for incomplete toxicity in zebrafish, such as effective sequestration or efflux mechanisms that engage at higher chloroquine concentrations to protect hair cells.

Further research is needed to fully investigate mechanisms of hair cell death in the presence of chloroquine and more broadly how this class of drugs affect patients in their everyday lives. In addition to potential side effects directly detrimental to auditory perception and vestibular function, changes in these perceptual outcomes can create an increase in anxiety, depression, and fatigue resulting in a decrease in quality of life ([@bib8]; [@bib12]; [@bib19]; [@bib30]; [@bib34]). Given the interest of chloroquine as a therapy for viral infections including Zika and SARS coronaviruses ([@bib1]), it will be important to consider monitoring auditory and vestibular function as these drugs are adopted to new therapies.

Author contributions {#sec5}
====================

Work was conceptualized by SND, JAS, EWR and DWR; Investigation carried out by SND, PW and EDC; Manuscript written and edited by SND, EWR and DWR.

Samantha N. Davis: Conceptualization, Investigation, Writing - original draft, Patricia Wu: Investigation, Writing - review & editing, Esra D. Camci: Investigation, Writing - review & editing, Julian A. Simon: Conceptualization, Writing - review & editing, Funding acquisition, Edwin W Rubel: Conceptualization, Writing - review & editing, Supervision, Funding acquisition. David W. Raible: Conceptualization, Writing - review & editing, Supervision, Funding acquisition.

This work was supported by the National Institutes of Deafness and other Communication Disorders R01DC005987, and Auditory Neuroscience Training Grant 10.13039/100000002NIH T32DC005361.
